The capital opens the genomic and clinical innovation unit with advanced technology and national approach.

By Deyanira Vázquez | Reporter

In Mexico City ( CDMX) They opened the Genomic and clinical innovation unitlocated in the MONTERREY TECHNOLOGY, equipped by him Translation Institute of Genomic Singularity (Itrasig). This strategic space of Tlalpan Innovation District He promoted precision medicine technologies for diagnosis and treatment of diseases such as HIV, Gram and sepsis. With an ability to process up to 14 thousand daily genetic tests, it strengthened the early response to infectious outbreaks.

The inauguration represented a decisive step to position Mexico on the border of genetic knowledge. The unit allowed the creation of a national genetic analysis platform, designed to integrate medical information and support public health policies. This effort was consolidated with scientific collaboration and alliances between academic institutions, private sector and federal government.

The first three unity projects defined their technological vocation and social orientation. The first consisted of a portable platform that measured the viral load of HIV-1 and CMV directly at clinical points without hospital infrastructure. The second developed a molecular tool that replaced the traditional Gram staining with a faster and more precise method.

Innovation with social impact

The third project focused on a molecular platform with artificial intelligence for the integral diagnosis of sepsis. These innovations improved access to rapid diagnoses and medical care in communities with hospital lag. In addition, they connected researchers with public and private institutions to strengthen the future of health.

The Holder of Innovation of the Ministry of Economy, Cecilia Bañuelosindicated that this advance coincided with the Mexico Planby promoting the transformation of knowledge into products with added value. He stressed that it was necessary to protect the generated knowledge and promote solutions that transcended laboratories towards everyday life.

For its part, the Mtra. Paulina CamposVice President of the Campus of Mexico City of the Monterrey Technologicalhighlighted the relevance of the project within the Tlalpan Innovation District. He explained that the collaboration between Academy, Federal Government and Private Initiative strengthened the technological ecosystem for the benefit of the country.

He Dr. Luis Alonso Herrera MontalvoNational Dean of the School of Medicine and Health Sciences of Tec de Monterreyaffirmed that the unit constituted a bridge between academic excellence and the entrepreneurial vision of the Itrasig. Its implementation generated scientific solutions applied to the main health challenges of the country.

Science and technological sovereignty

The three projects evolved towards portable genetic diagnostic formats Nanolucia low -cost molecular analysis laboratory. Along with artificial intelligence Pablo Aideveloped in Mexico, facilitated their use in hospitals, clinics and rural communities.

These technologies guaranteed timely diagnoses during health emergencies, strengthening the national medical response. The portable model also offered a sustainable and scalable alternative for the early detection of infectious diseases in different regions of the country.

The inauguration of the unit symbolized the commitment of the Monterrey Technological with scientific innovation applied to social welfare. Your alliance with the Itrasig He promoted an ecosystem where research, innovation and entrepreneurship converged to create concrete solutions.

The Genomic and Clinical Innovation Unit was consolidated as a continental reference in Biotechnology and Personalized Medicine. In this space, interdisciplinary collaboration, the training of scientific talent and technological transfer were promoted.

The project also strengthened Mexico’s technological sovereignty, reducing the dependence of international genetic diagnosis services. In the long term, its impact contributed to modernize the medical infrastructure and to position the CDMX as the leading center of biomedical innovation in Latin America. –SN–

Connect with News Society! Subscribe to our YouTube channel and activate notifications, or follow us on social networks: Facebook, Twitter and Instagram.

Also, we invite you to join our real -time information channel through Telegram.